SCHEMBL3946183

SCHEMBL3946183

COc1ccccc1NC(=O)Oc1[nH]c2ccc(NS(=O)(=O)c3ccc(C(C)(C)C)cc3)cc2c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.49
SERPINE1 P05121 1/20 0.46
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 3/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.41
AVPR2 P30518 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3948167 0.90 BRD4 (0.50) BRD4SERPINE1ALDH1A1KMT2ALMNA
SCHEMBL3944931 0.90 BRD4 (0.50) BRD4SERPINE1ALDH1A1KMT2AMEN1
SCHEMBL3945365 0.89 BRD4 (0.55) BRD4SERPINE1ALDH1A1KMT2AMAPT
SCHEMBL3944932 0.89 BRD4 (0.51) BRD4SERPINE1ALDH1A1KMT2ALMNA
SCHEMBL3951022 0.88 BRD4 (0.49) BRD4SERPINE1ALDH1A1KMT2ALMNA
SCHEMBL3942384 0.88 BRD4 (0.52) BRD4SERPINE1ALDH1A1KMT2AKDM4E
SCHEMBL4116635 0.87 BRD4 (0.51) BRD4SERPINE1ALDH1A1KMT2AKDM4E
SCHEMBL3951295 0.87 BRD4 (0.52) BRD4SERPINE1ALDH1A1KMT2ALMNA
SCHEMBL3947998 0.87 BRD4 (0.52) BRD4SERPINE1ALDH1A1KMT2ALMNA
SCHEMBL3943378 0.86 BRD4 (0.52) BRD4SERPINE1ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802572-B1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AG (DE) 2009-04-22 EP claimed
EP-1802572-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-04 EP claimed
WO-2006032541-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-03-30 WO claimed
EP-1802572-B1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AG (DE) 2009-04-22 EP disclosed
EP-1802572-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-04 EP disclosed
WO-2006032541-A1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed